Header Logo

Connection

Mayer Davidson to Blood Glucose

Back to Details
This is a "connection" page, showing publications Mayer Davidson has written about Blood Glucose.
Mayer Davidson
Connection Strength
7.132
Blood Glucose
  1. Glycaemic treatment of newly diagnosed type 2 diabetes. Diabetes Obes Metab. 2024 Nov; 26(11):5492-5493.
    View in: PubMed
    Score: 0.833
  2. Real-world evidence for computerized insulin dose-adjustment algorithms in the effective use of continuous glucose monitoring by primary care clinicians. Diabetes Obes Metab. 2024 Aug; 26(8):3475-3477.
    View in: PubMed
    Score: 0.821
  3. Response to Umpierrez et al. Diabetes Obes Metab. 2019 10; 21(10):2344-2345.
    View in: PubMed
    Score: 0.584
  4. Diagnosing diabetes with glucose criteria: worshiping a false God. Diabetes Care. 2011 Feb; 34(2):524-6.
    View in: PubMed
    Score: 0.325
  5. Counterpoint: postprandial glucose levels are not a clinically important treatment target. Diabetes Care. 2010 Aug; 33(8):1908-10.
    View in: PubMed
    Score: 0.314
  6. The relationship of glycaemic control and triglycerides in patients with diabetes mellitus: a PreCIS Database Study. Diabetes Obes Metab. 2009 Feb; 11(2):118-22.
    View in: PubMed
    Score: 0.270
  7. Lowering the criterion for impaired fasting glucose will not provide clinical benefit. Diabetes Care. 2003 Dec; 26(12):3329-30.
    View in: PubMed
    Score: 0.198
  8. Editor's comment: "It ain't necessarily so". Diabetes Care. 2002 Nov; 25(11):2116.
    View in: PubMed
    Score: 0.184
  9. Counterpoint: the oral glucose tolerance test is superfluous. Diabetes Care. 2002 Oct; 25(10):1883-5.
    View in: PubMed
    Score: 0.182
  10. Metformin Should Not Be Used to Treat Prediabetes. Diabetes Care. 2020 09; 43(9):1983-1987.
    View in: PubMed
    Score: 0.158
  11. Revisiting the oral glucose tolerance test criterion for the diagnosis of diabetes. J Gen Intern Med. 2000 Aug; 15(8):551-5.
    View in: PubMed
    Score: 0.157
  12. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA. 1999 Apr 07; 281(13):1203-10.
    View in: PubMed
    Score: 0.143
  13. Delayed response to an injection of U-500 regular insulin is not rare. J Diabetes. 2019 Jul; 11(7):519-521.
    View in: PubMed
    Score: 0.143
  14. Continuous Glucose Monitoring in Patients With Type 1 Diabetes Taking Insulin Injections. JAMA. 2017 01 24; 317(4):363-364.
    View in: PubMed
    Score: 0.123
  15. A Reappraisal of Prediabetes. J Clin Endocrinol Metab. 2016 07; 101(7):2628-35.
    View in: PubMed
    Score: 0.118
  16. An alternative approach to the diagnosis of diabetes with a review of the literature. Diabetes Care. 1995 Jul; 18(7):1065-71.
    View in: PubMed
    Score: 0.110
  17. Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2014 Oct; 99(10):3551-60.
    View in: PubMed
    Score: 0.103
  18. Rationale, design, and implementation of a cluster randomized trial using certified diabetes educators to intensify treatment for glycemia, blood pressure and lipid control: REMEDIES 4D. Contemp Clin Trials. 2014 Sep; 39(1):124-31.
    View in: PubMed
    Score: 0.103
  19. Epidemiological ramifications of diagnosing diabetes with HbA1c levels. J Diabetes Complications. 2014 Jul-Aug; 28(4):464-9.
    View in: PubMed
    Score: 0.101
  20. Protein and fat effects on glucose responses and insulin requirements in subjects with insulin-dependent diabetes mellitus. Am J Clin Nutr. 1993 Oct; 58(4):555-60.
    View in: PubMed
    Score: 0.098
  21. The challenge of blood glucose management in diabetic patients receiving enteral or parenteral nutrition. JPEN J Parenter Enteral Nutr. 1993 Jan-Feb; 17(1):1-2.
    View in: PubMed
    Score: 0.093
  22. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes. BMJ. 2012 Feb 27; 344:e486.
    View in: PubMed
    Score: 0.088
  23. Effects of various enteral feeding products on postprandial blood glucose response in patients with type I diabetes. JPEN J Parenter Enteral Nutr. 1992 Jan-Feb; 16(1):69-74.
    View in: PubMed
    Score: 0.087
  24. A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failure. Endocr Pract. 2011 May-Jun; 17(3):395-403.
    View in: PubMed
    Score: 0.083
  25. Correction to the 2010 report on the diagnosis and classification of diabetes. Diabetes Care. 2010 Apr; 33(4):e57.
    View in: PubMed
    Score: 0.077
  26. How our current medical care system fails people with diabetes: lack of timely, appropriate clinical decisions. Diabetes Care. 2009 Feb; 32(2):370-2.
    View in: PubMed
    Score: 0.071
  27. Screening for diabetes mellitus. Ann Intern Med. 1989 Jan 15; 110(2):168.
    View in: PubMed
    Score: 0.071
  28. No need for the needle (at first). Diabetes Care. 2008 Oct; 31(10):2070-1.
    View in: PubMed
    Score: 0.069
  29. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab. 2008 Jul; 93(7):2447-53.
    View in: PubMed
    Score: 0.067
  30. Utility of A1C for diabetes screening in the 1999 2004 NHANES population. Diabetes Care. 2007 Sep; 30(9):2233-5.
    View in: PubMed
    Score: 0.063
  31. The dilemma of self-monitoring of blood glucose. Diabetologia. 2007 Mar; 50(3):497-9.
    View in: PubMed
    Score: 0.062
  32. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care. 2007 Mar; 30(3):753-9.
    View in: PubMed
    Score: 0.062
  33. The role of glucosylated serum albumin in monitoring glycemic control in stable insulin-requiring diabetic out-patients. J Clin Endocrinol Metab. 1987 Feb; 64(2):269-73.
    View in: PubMed
    Score: 0.062
  34. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2006 Aug; 49(8):1711-21.
    View in: PubMed
    Score: 0.060
  35. Comparison of the glycemic effects of rosiglitazone and pioglitazone in triple oral therapy in type 2 diabetes. Diabetes Care. 2006 Jun; 29(6):1395-6.
    View in: PubMed
    Score: 0.059
  36. Futility of self-monitoring of blood glucose without algorithms for adjusting insulin doses. Diabetes Care. 1986 Mar-Apr; 9(2):209-10.
    View in: PubMed
    Score: 0.058
  37. Counterpoint: Self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money. Diabetes Care. 2005 Jun; 28(6):1531-3.
    View in: PubMed
    Score: 0.055
  38. Early insulin therapy for type 2 diabetic patients: more cost than benefit. Diabetes Care. 2005 Jan; 28(1):222-4.
    View in: PubMed
    Score: 0.053
  39. Indirect support for the use of supplemental insulin in hospitalized insulin-requiring diabetic patients. Diabetes Care. 2004 Sep; 27(9):2260-1.
    View in: PubMed
    Score: 0.052
  40. Effect of Pancreas Tonic (an ayurvedic herbal supplement) in type 2 diabetes mellitus. Metabolism. 2004 Sep; 53(9):1166-73.
    View in: PubMed
    Score: 0.052
  41. Type-1 diabetes mellitus with insufficient serum immunoreactive insulin elevation after subcutaneous NPH-insulin injection. Diabetes Res Clin Pract. 2004 Jun; 64(3):229.
    View in: PubMed
    Score: 0.051
  42. Novel risk factors for atherosclerosis. JAMA. 2004 Jan 21; 291(3):301; author reply 301-2.
    View in: PubMed
    Score: 0.050
  43. HbA(1c) measurements do not improve the detection of type 2 diabetes in a randomly selected population. Diabetes Care. 2001 Nov; 24(11):2017-8.
    View in: PubMed
    Score: 0.043
  44. Controlling blood glucose levels in patients with type 2 diabetes mellitus. An evidence-based policy statement by the American Academy of Family Physicians and American Diabetes Association. J Fam Pract. 2000 May; 49(5):453-60.
    View in: PubMed
    Score: 0.039
  45. Treatment of non-insulin-dependent diabetes mellitus. Mayo Clin Proc. 1997 Jan; 72(1):92.
    View in: PubMed
    Score: 0.031
  46. Addition of hydrolyzed guar to enteral feeding products in type I diabetic patients. Diabetes Care. 1996 Aug; 19(8):899-900.
    View in: PubMed
    Score: 0.030
  47. Maximal dose glyburide therapy in markedly symptomatic patients with type 2 diabetes: a new use for an old friend. J Clin Endocrinol Metab. 1996 Jul; 81(7):2423-7.
    View in: PubMed
    Score: 0.030
  48. Reduction of hyperinsulinemia by glyburide--scientific fact or advertising fiction? Diabetes Care. 1992 May; 15(5):719-20.
    View in: PubMed
    Score: 0.022
  49. Integrating an Automated Diabetes Management System into the family management of children with type 1 diabetes: results from a 12-month randomized controlled technology trial. Diabetes Care. 2012 Mar; 35(3):498-502.
    View in: PubMed
    Score: 0.022
  50. Successful treatment of unusual case of brittle diabetes with sulfated beef insulin. Diabetes Care. 1991 Nov; 14(11):1109-10.
    View in: PubMed
    Score: 0.021
  51. Antidiabetic action of vanadyl in rats independent of in vivo insulin-receptor kinase activity. Diabetes. 1991 Apr; 40(4):492-8.
    View in: PubMed
    Score: 0.021
  52. Metabolic and thermal responses to Piromen in man. J Clin Endocrinol Metab. 1971 Feb; 32(2):179-87.
    View in: PubMed
    Score: 0.020
  53. Modern management of the insulin-requiring patient. Compr Ther. 1990 Jul; 16(7):49-55.
    View in: PubMed
    Score: 0.020
  54. Inhibition of sleep-induced growth hormone secretion: no effect on diabetic control. Diabetes Care. 1990 Jul; 13(7):813-4.
    View in: PubMed
    Score: 0.020
  55. Lack of glucose elevation after simulated tube feeding with a low-carbohydrate, high-fat enteral formula in patients with type I diabetes. Am J Med. 1989 Aug; 87(2):178-82.
    View in: PubMed
    Score: 0.018
  56. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009 Jan; 32(1):193-203.
    View in: PubMed
    Score: 0.017
  57. Use oral hypoglycemics with caution...but keep caution in context. Geriatrics. 1988 Aug; 43(8):83-4.
    View in: PubMed
    Score: 0.017
  58. Glucose transport is rate limiting for skeletal muscle glucose metabolism in normal and STZ-induced diabetic rats. Diabetes. 1988 Jul; 37(7):885-90.
    View in: PubMed
    Score: 0.017
  59. Effect of storage on action of NPH and regular insulin mixtures. Diabetes Care. 1987 Nov-Dec; 10(6):799-800.
    View in: PubMed
    Score: 0.016
  60. Failure of synalbumin to exhibit insulin antagonism in vivo. Diabetes. 1967 Jun; 16(6):386-94.
    View in: PubMed
    Score: 0.016
  61. Idiopathic fasting hypoglycemia in an adult. Am J Med. 1987 Feb; 82(2):303-6.
    View in: PubMed
    Score: 0.015
  62. Pathogenesis of type 2 diabetes mellitus: an interpretation of current data. Am J Med Sci. 1986 Jul; 292(1):35-9.
    View in: PubMed
    Score: 0.015
  63. Hyperthyroid Graves' disease causes insulin antagonism. J Clin Endocrinol Metab. 1985 May; 60(5):1038-41.
    View in: PubMed
    Score: 0.014
  64. Pathogenesis of impaired glucose tolerance and type II diabetes mellitus--current status. West J Med. 1985 Feb; 142(2):219-29.
    View in: PubMed
    Score: 0.013
  65. Effects of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men. Diabetes Care. 1983 Jul-Aug; 6(4):319-27.
    View in: PubMed
    Score: 0.012
  66. Insulin binding and action in isolated rat hepatocytes: effect of obesity and fasting. Am J Physiol. 1982 Sep; 243(3):E240-5.
    View in: PubMed
    Score: 0.011
  67. Hepatic effects of glucose and insulin independent of cyclic nucleotide changes. Acta Diabetol Lat. 1981 Oct-Dec; 18(4):297-310.
    View in: PubMed
    Score: 0.011
  68. Perioperative management of diabetes mellitus. Anesthesiology. 1981 Aug; 55(2):104-9.
    View in: PubMed
    Score: 0.011
  69. The case for routinely testing the first-voided urine specimen. Diabetes Care. 1981 May-Jun; 4(3):443-4.
    View in: PubMed
    Score: 0.010
  70. Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance. Diabetes. 2001 May; 50(5):1186-92.
    View in: PubMed
    Score: 0.010
  71. Role of ketogenesis in urinary sodium excretion: elucidation by nicotinic acid administration during fasting. J Clin Endocrinol Metab. 1979 Dec; 49(6):818-23.
    View in: PubMed
    Score: 0.009
  72. The effect of aging on carbohydrate metabolism: a review of the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly. Metabolism. 1979 Jun; 28(6):688-705.
    View in: PubMed
    Score: 0.009
  73. Metabolic studies in familial partial lipodystrophy of the lower trunk and extremities. Diabetologia. 1975 Dec; 11(6):561-8.
    View in: PubMed
    Score: 0.007
  74. Growth hormone responses to fructose in diabetes mellitus. Acta Endocrinol (Copenh). 1974 Mar; 75(3):497-502.
    View in: PubMed
    Score: 0.006
  75. Phenobarbital treatment enhances insulin-mediated glucose metabolism and improves lipid metabolism in the diabetic rat. Metabolism. 1994 Mar; 43(3):348-56.
    View in: PubMed
    Score: 0.006
  76. Role of growth hormone in the alteration of carbohydrate metabolism induced by oral contraceptive agents. J Clin Endocrinol Metab. 1973 Feb; 36(2):246-55.
    View in: PubMed
    Score: 0.006
  77. Studies on the mechanism of pentobarbital-induced glucose intolerance. Horm Metab Res. 1971 Jul; 3(4):243-7.
    View in: PubMed
    Score: 0.005
  78. Effect of isocaloric substitution of chocolate cake for potato in type I diabetic patients. Diabetes Care. 1990 Aug; 13(8):888-92.
    View in: PubMed
    Score: 0.005
  79. The variability in the action of unmodified insulin is more dependent on changes in tissue insulin sensitivity than on insulin absorption. Diabet Med. 1988 Oct; 5(7):662-6.
    View in: PubMed
    Score: 0.004
  80. Exogenous insulin therapy slows weight loss in type 2 diabetic patients. Int J Obes. 1988; 12(2):149-55.
    View in: PubMed
    Score: 0.004
  81. Effects of reserpine on biological clocks for metabolic fuels during starvation in man. Diabetes. 1968; 17:312.
    View in: PubMed
    Score: 0.004
  82. Insulin antagonism is not a primary abnormality of amyotrophic lateral sclerois but is related to disease severity. J Clin Endocrinol Metab. 1986 Jul; 63(1):41-6.
    View in: PubMed
    Score: 0.004
  83. Insulin secretion and action in the hyperthyroid rat. Horm Metab Res. 1985 Aug; 17(8):383-6.
    View in: PubMed
    Score: 0.003
  84. Diabetes mellitus. Ann Intern Med. 1982 May; 96(5):635-49.
    View in: PubMed
    Score: 0.003
  85. The effect of potassium chloride infusion on insulin secretion in vivo. Horm Metab Res. 1972 Mar; 4(2):64-8.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.